Liver Cancer Clinical Trials in Boston, Massachusetts

5 studies are recruiting for liver cancer in Boston, Massachusetts right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. National Liver Cancer Screening Trial

   The National Liver Cancer Screening Trial is an adaptive randomized phase IV Trial comparing ultrasound-based versus biomarker-based screening in 5500 patients with cirrhosis from any etiology or patients with chronic hepatitis B infection. Eligible patients will be randomized in a 1:1 fashion to A…

   Stage

   Phase 4

   Ages

   18 to 85

   Site

   Massachusetts General Hospital, Boston, Massachusetts

   Locations

   19 in total

   Run by

   University of Texas Southwestern Medical Center

   See if you can join NCT06084234 on ClinicalTrials.gov

2. Distance-Based Exercise to Preserve Function and Prevent Disability

   This clinical trial studies whether an exercise program can be successfully delivered to patients receiving treatment for cancer through virtual sessions and allow patients to exercise in their own home. Treatments for cancer can cause side effects such as fatigue and loss of strength. These side e…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Dana-Farber Cancer Institute, Boston, Massachusetts

   Locations

   18 in total

   Run by

   Alliance for Clinical Trials in Oncology

   See if you can join NCT07059884 on ClinicalTrials.gov

3. Jump: MR Simulation For Radiation Therapy Master Protocol

   This is a master protocol for a prospective Phase I-II study evaluating feasibility and efficacy of incorporating magnetic resonance imaging (MRI) simulation into the planning of radiation treatments.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Brigham and Women Hospital, Boston, Massachusetts

   Locations

   2 in total

   Run by

   Brigham and Women's Hospital

   See if you can join NCT04545957 on ClinicalTrials.gov

4. ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma

   Open-label, dose escalation, multi-center, Phase I/II clinical trial to assess the safety/tolerability and determine the recommended Phase II Dose (RP2D) of ET140203 T-cells in pediatric subjects who are AFP-positive/HLA-A2-positive and have relapsed/refractory HB, HCN-NOS, or HCC.

   Stage

   Phase 1

   Ages

   1 to 21

   Site

   Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts

   Locations

   4 in total

   Run by

   Eureka Therapeutics Inc.

   See if you can join NCT04634357 on ClinicalTrials.gov

5. Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma

   This research study is studying an immunotherapy drug (pembrolizumab or KEYTRUDA) as a possible treatment for pediatric hepatocellular carcinoma or hepatocellular neoplasm not otherwise specified (HCN NOS).

   Stage

   Phase 2

   Ages

   0 to 30

   Site

   Children's Hospital Boston, Boston, Massachusetts

   Locations

   5 in total

   Run by

   Allison O'Neill, MD

   See if you can join NCT04134559 on ClinicalTrials.gov